“This engagement reflects the trust public institutions place in XBP to enhance service reliability and elevate operational standards,” said Vitalie Robu, President, XBP Europe. “Our solutions are ...
Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...
STOCKHOLM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a workflow automation leader that leverages decades of industry experience, a ...
An announcement from Wallenstam AB ( ($SE:WALL.B) ) is now available. Wallenstam has launched a revised framework for green financing in ...
Researchers have created an oral medication that could work alone or with GLP-1 drugs to improve metabolic health while ...
Senzime AB ( ($SE:SEZI) ) just unveiled an announcement. Senzime AB has secured a significant order from a leading NHS hospital trust in the UK ...
High-intensity interval training boosts fitness and muscle endurance more effectively than traditional home exercise programs in people recently diagnosed with inflammatory muscle disease. That is the ...